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A b s t r a c t  
Controlled release technology has emerged to be an important area of research in the field of novel 
drug delivery system. Being a member of controlled release system, microspheres are very useful 
for achieving therapeutic response for improving patient compliance. Microspheres of diclofenac 
potassium were prepared by using cold gelation technique with the help of a biodegradable polymer-
agarose. Beads were prepared by dropping a hot aqueous agar solution in to a beaker containing a 
mixture of chilled light liquid paraffin and water. pH of water was adjusted 1.60 by adding 
concentrated hydrochloric acid to reduce the prior diffusion of diclofenac potassium. Drug release 
profile (in-vitro release), swelling index, particle size analysis, entrapment of drug into beads were 
investigated. Scanning electron microscopy (SEM) was carried out for characterisation of beads. 
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Introduction 
Controlled release technology now forms the essence of modern 
and future drug delivery system for last several decades in terms 
of clinical efficacy and patient compliances1. For this purpose, 
agar, a natural polymer is used for preparation of diclofenac 
potassium microsphere by a modified gelation method2. Natural 
polymers have lots of advantages over synthetic polymers as safe 
and non-toxic in nature, highly bio-compatible and bio-degradable, 
very much environment and eco-friendly. Some organic materials 
are required to dissolve synthetic polymers, which causes 
possible toxicity, explosion hazards3. Agar is prepared from 
various species of Geledium amansii and other red algae. It has 
molecular weight 120000, gelling point 350C to 450C for 
1.5%(w/v). At 900C agar forms a colloidal substance with water 
and forms a solid gel upon cooling below its gelling point. This 
property tends a suitable balance between easy melting and good 
gel stability at relatively high temperatures. In the gel agar forms 
double helices which linked together forms bundle of network4. 
Diclofenac potassium (DP) is a mono potassium salt of benzoic 
acetic acid derivative (mol. wt 334.25). It is a very popular and 
most useful non-steroidal anti-inflammatory agent which is widely 
use in rheumatoid arthritis5 and other inflammatory conditions6. It 
is more potent than diclofenac sodium7. The biological half life of 
diclofenac potassium is about 1-2 hours and the usual oral dose is 
50mg, 2-4 times a day8. Therefore it requires multiple dosing to 
maintain therapeutic blood level of the drug. The most frequent 
adverse side effects of diclofenac potassium on long term 
administration are gastrointestinal disturbances, hyper acidity, 
peptic ulceration and gastrointestinal bleeding9-10. For this 
purpose agarose beads were prepared for control drug delivery 
system, increasing surface area and incorporating cross linking 
divalent metal (CaCl2) into agar beads. 
Materials and Methods 
Materials 
Diclofenac potassium IP was received as a gift sample from U S 
Vitamins Ltd, Gujarat, India. Agarose and calcium chloride 
(analytical grade) were purchased from Loba Chemicals and 
Qualigens India Ltd, respectively. All other ingredient used of 
analytical grade.  
Methods 
Preparation of microbeads 
Agar coated diclofenac potassium beads were prepared by 
modified technique followed by work of E.A.EI.Fattah11. At first a 
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gelation medium was prepared by dissolving different quantities of 
agar (W/V) with water and heated slowly. Drug polymer solution 
was prepared by dispersing the drug slowly into previously 
prepared agar gel with continuous and uniform stirring for 3hours. 
Bubble free dispersion medium was extruded through glass 
syringe (20G) in a drop wise fashion into the beaker which is filled 
with chilled acidified water (pH 1.6), CaCl2 and liquid paraffin.  
The agitation was carried out by magnetic stirrer at 200rpm.when 
hot gel was poured in to chilled paraffin, the droplet become 
sphere due to paraffin and hard due to the temperature below 
gelling point of agar. After completion of beads formation the 
beads were removed by decanting the paraffin and acidified water 
mixture and washed with hexane to remove the paraffin. The 
beads were dried at 300C under reduced pressure till they 
attained constant weight. This method was repeated for different 
formulations by changing the quantities of agar and CaCl2.  
 
Yield of beads 
To determine the yield following formula was employed. 
 
Yield of beads= 
          X 100 
 
Where W1 = the weight summation of drug, polymers and cross 
linking agents, W2 = the weight of the beads prepared 
experimentally. The mean of three determinations was reported in 
Table-2. 
Determination of drug entrapment efficiency 
To evaluate the drug content inside the beads, the digestion 
method was applied. The drug – loaded beads (equivalent to 
50mg) were pulverized and incubated in 50ml of 0.1N NaOH 
solution at room temperature for 24h. After the interval the 
solution was stirred, filtered, diluted and assayed 
spectrophotometically at 276nm. 
 
The drug entrapment efficiency = 
           X 100 
 
Where X1 = the theoretical amount of the drug present in the 
beads, X2 = the experimental amount of the drug present in the 
beads. The mean of three determinations was reported in Table-
2. 
Particle size analysis 
The particle sizes of the prepared microbeads were determined 
using the optical microscopy method. It was the most direct 
method for size distribution measurement. The prepared 
microbeads were mounted in light liquid paraffin and the 
diameters of 100 particles were measured by means of an optical 
microscope equipped with a calibrated ocular micrometer. Then 
the mean diameter was calculated and represented in Table-2 
In vitro release study 
The dissolution profile of DP- microsphere was determined by 
using USP (Type-I) basket type dissolution test apparatus taking 
900ml of phosphate buffer (pH 7.4) solution. The study was 
carried out for eight hours. The dissolution medium was 
maintained at a temperature of 37±10C. The basket was covered 
by 100 mesh nylon cloth and rotated at 50 rpm. The 10ml of 
sample was taken at every 1h interval and simultaneously equal 
quantity of the corresponding blank dissolution medium was 
added to the dissolution apparatus. The sample was filtered and 
suitably diluted to determine the absorbance at 276nm in double 
beam UV spectrophotometer (CHEMITO-2500). Cumulative 
percentages of drug release from the microbeads were 
determined at different intervals and plotted in figures. 
Results and Discussions 
The microbeads were sufficiently hard and spherical in shape. 
The beads were characterized for their particle size by 
microscopic method, drug loading efficiency and scanning 
electron microscopy. 
Scanning Electron Microscopy (SEM) Analysis:  
The surface analysis of drug loaded beads was done by Scanning 
electron microscope (Model JEOL JSM-6360, Japan). From the 
scanning electron microscopy analysis (Fig 1-2) it was found that, 
microspheres prepared by cold gelation method were spherical, 
non-aggregated and porous. The surface of the blank 
microsphere were smooth where as drug loaded placebos were 
slightly rough than blank placebos. The study of drug loaded 
beads showed the presence of drug particles on the surface and 
that might be factor for initial release of drug by bursting effect. 
 
Effect of polymer concentration on in-vitro DP release 
from agar beads:  
The in-vitro release patterns of diclofenac potassium in different 
polymer concentrations were studied and were shown in fig-3; 
here agar was used in all twelve formulations at a ratio 1:1, 1:2 
and 1:3. The release pattern showed the initial bursting effect, 
followed by slow release. Agar has a popular gelling effect, when 
it comes contact with buffer medium; it starts partially hydrated 
and forms a gel layer. More quantities of polymer provides 
increasing amount of viscous gel layers and soluble drugs were 
diffused from gel layer in a decreased rate fashion. It may happen 
as the drug release channel length may increase with reduced 
porosity and high tortuosity as gel layer was increased. This factor 
can be attributed to the reduction of release rate with increment of 
polymer level of agar beads.  
Effect of electrolyte concentration on in-vitro DP 
release from agar beads:  
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Calcium chloride was used as electrolyte at different 
concentration in all twelve formulations. Formula code F1, F2, F3 
contains 4%, Formula code F4, F5, F6 contains 6%, Formula 
code F7, F8, F9 contains 8% and Formula code F10, F11, F12 
contains 10% of electrolytes. Release rate of drug increased with 
the increasing amount of the electrolyte followed by first group 
released 62% (max) and 50%(min) where as last group released 
87%(max) and 77%(min)(Fig-4). It may happen due to salting out 
of electrolytes. When beads containing electrolyte come contact 
to buffer system, electrolyte dissolve out rapidly from beads 
creating channels through which dissolution medium can get into 
and leach the drug out of the beads.   
Conclusion 
Diclofenac potassium loaded microspheres were prepared 
successfully by cold gelation method using the combination of 
agar and calcium chloride in different ratios. It was observed that 
the prepared microspheres were spherical, free flowing, high 
percentage entrapment efficiency and high percentage of yielding 
capacity.  
The in-vitro controlled release of DP from the prepared 
microspheres formulations have been established in this study. It 
also might be said that higher concentration of agarose along with 
lower percentage of electrolytes had a higher retarding capacity.  
However, the in-vitro release characteristics of the drug from the 
microspheres are subject to confirmation in animal and human 
studies for coming into conclusion of enhanced bioavailability and 
reduced dose frequency to improve patient compliance, which is 
under progress in our laboratory. 
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Figure 3: Effect of polymer on release rate of twelve formulations of agarose beads. 
 
 
 
 
 
Figure 4: Effect of electrolyte on release rate of four formulations of agarose beads. 
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Table 1 : Quantities of different ingredients used in preparing microbeads. 
 
Formulation 
Code 
Diclofenac 
potassium 
(mg) 
Agar 
 
(mg) 
Cross linking 
Agent (CaCl2) 
(%) 
Stirring 
speed 
(rpm) 
F1 200 200 4 200 
F2 200 400 4 200 
F3 200 600 4 200 
F4 200 200 6 200 
F5 200 400 6 200 
F6 200 600 6 200 
F7 200 200 8 200 
F8 200 400 8 200 
F9 200 600 8 200 
F10 200 200 10 200 
F11 200 400 10 200 
F12 200 600 10 200 
 
Table 2: Percentages of yield and the drug entrapment as well as the mean diameter of microbeads. 
 
Bead Code Yield ( % ) 
Entrapment 
( % ) 
Mean Diameter 
(mm) 
F1 79.25 92.30 0.78 
F2 77.10 89.73 0.92 
F3 72.44 88.33 0.93 
F4 74.21 90.88 0.96 
F5 86.63 88.32 0.98 
F6 70.68 88.70 0.80 
F7 68.36 83.26 0.85 
F8 78.97 81.42 0.92 
F9 72.38 89.47 0.96 
F10 79.45 86.58 0.87 
F11 83.12 84.25 0.89 
F12 89.52 81.12 0.94 
 
 
 
 
 
 
 
 
